VEGFA and neoplasm: PRDX1, a primary target of peroxisome-derived H2O2 [134], supports tumor growth and angiogenesis in PC3-M xenografts by promoting vascular endothelial growth factor (VEGF) expression in a Toll-like receptor 4 (TLR4)-dependent manner [165].